Schroder Investment Management Group’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-30,256
| Closed | -$291K | – | 1226 |
|
2023
Q3 | $291K | Buy |
+30,256
| New | +$291K | ﹤0.01% | 1142 |
|
2023
Q2 | – | Sell |
-98,445
| Closed | -$1.04M | – | 1257 |
|
2023
Q1 | $1.04M | Sell |
98,445
-247,764
| -72% | -$2.61M | ﹤0.01% | 1053 |
|
2022
Q4 | $4.29M | Sell |
346,209
-155,368
| -31% | -$1.93M | 0.01% | 806 |
|
2022
Q3 | $5.2M | Buy |
501,577
+476,201
| +1,877% | +$4.93M | 0.01% | 764 |
|
2022
Q2 | $293K | Sell |
25,376
-9,618
| -27% | -$111K | ﹤0.01% | 1233 |
|
2022
Q1 | $451K | Sell |
34,994
-78,240
| -69% | -$1.01M | ﹤0.01% | 1231 |
|
2021
Q4 | $1.32M | Sell |
113,234
-70,840
| -38% | -$826K | ﹤0.01% | 997 |
|
2021
Q3 | $2.4M | Hold |
184,074
| – | – | ﹤0.01% | 943 |
|
2021
Q2 | $2.37M | Buy |
184,074
+86,029
| +88% | +$1.11M | ﹤0.01% | 982 |
|
2021
Q1 | $1.1M | Sell |
98,045
-13,288
| -12% | -$149K | ﹤0.01% | 1142 |
|
2020
Q4 | $1.27M | Buy |
111,333
+3,522
| +3% | +$40.1K | ﹤0.01% | 1084 |
|
2020
Q3 | $1M | Buy |
+107,811
| New | +$1M | ﹤0.01% | 1016 |
|